TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study of 400 people with type 1 or type 2 diabetes found that more time in the normal glucose range was associated with better quality of life the next day. Greater glucose variability was also associated with better next-day well-being, a result researchers said may reflect the burden of trying to prevent every fluctuation. The findings show associations, not that glucose swings improve health.
People with type 1 or type 2 diabetes reported better quality of life the day after spending more time in the normal glucose range, but they also tended to report better well-being after days with greater glucose variability, according to an analysis of 400 participants. The researchers say the second association may reflect the burden of trying to suppress every fluctuation; the study does not show that glucose swings improve health, and its findings are due to be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Milan.
The analysis used data from the German-funded PRO-MENTAL study. Participants wore continuous glucose monitors and rated their quality of life each day for 14 consecutive days. The daily assessment was based on the WHO-5 questionnaire, which asks about feeling cheerful, calm, active, rested and interested in daily life. Participants also reported sleep quality, stress, mood and energy.
Researchers compared those reports with glucose measures, including time below 70 milligrams per deciliter, time above 180 mg/dL, time in a 70–140 mg/dL range, and glucose variability. Statistical models examined whether glucose and well-being measures on one day were associated with quality of life the following day. The models accounted for age, sex and diabetes type, among other factors, including the previous day’s quality-of-life rating.
The sample included 400 people: 72% had type 1 diabetes and 28% type 2; 55% were female. Their median age was reported as 47 years, with a range of 32 to 63, and mean HbA1c was 7.6%. More time in the normal glucose range and greater-than-usual glucose variability on one day were each associated with higher quality-of-life ratings the next day. Time spent above or below the study’s stated safe ranges was not significantly associated with next-day quality of life. Same-day glucose measurements were also not associated with same-day quality of life.
The Burden Behind Glucose Targets
The result highlights a question for diabetes care: how can glucose management support health while allowing people to participate in daily life? The study’s two associations point in different directions only at first glance: more time in the normal range was linked with better next-day well-being, while greater variability was also linked with it. The researchers do not interpret this as evidence that looser control is beneficial.
Instead, the team suggests that people who try to eliminate ordinary glucose changes may sometimes take on restrictions or extra effort that affect their quality of life. The data did not directly establish that explanation, however. If it is borne out in further work, the findings could help clinicians and patients discuss not just glucose metrics but also the practical burden of management and the activities people feel able to do safely.
Sleep and energy were also associated with next-day quality of life: better sleep the preceding night and higher reported energy the previous day tracked with improved well-being. These findings place glucose patterns among several factors connected with how participants felt, rather than presenting a single glucose measure as a complete account of daily life.
Fourteen Days of Daily Tracking
The project was conducted by Professor Dominic Ehrmann of FIDAM, the Research Institute Diabetes Academy Mergentheim in Germany, and colleagues. It draws on continuous glucose monitoring (CGM), which records glucose levels over time, alongside ecological momentary assessment, a method for collecting brief reports in participants’ everyday settings.
Glucose variability describes how much glucose rises and falls; it is distinct from time spent within a target range. The study defined its normal range as 70–140 mg/dL, while it measured time below 70 mg/dL and above 180 mg/dL separately. The authors’ reported association between variability and well-being therefore does not mean that more time outside safe levels was linked with improved quality of life; those measures were not significantly associated with next-day ratings.
The research was funded by the German Center for Diabetes Research. The findings are being presented at the EASD meeting scheduled for Sept. 28 to Oct. 2, 2026, in Milan. The supplied report describes an observational analysis of a 14-day period, rather than an intervention that assigned participants different glucose-management strategies.
“Days with higher time in the normal safe range for blood sugar were followed by days on which individuals with type 1 and type 2 diabetes reported better quality of life.”
— The study authors
What the Associations Cannot Show
The analysis found associations, not cause and effect. It cannot establish that glucose variability itself improves well-being, or that efforts to reduce variability caused lower quality of life. The proposed explanation about self-imposed restrictions is an interpretation from the researchers, not a direct finding that the study measured.
The report does not provide the size of the associations, details about how participants’ diabetes-management approaches differed, or evidence that the results apply beyond the people and 14-day period studied. It also does not establish whether the pattern would hold over longer periods or for people with different treatment needs. The researchers reported no significant relationship between time above or below their stated safe ranges and next-day quality of life; that result does not establish that such exposure is harmless.
Presentation and Further Study
The findings are scheduled for presentation at the EASD Annual Meeting in Milan, running Sept. 28–Oct. 2, 2026. The supplied report does not describe a planned clinical intervention or a change to treatment guidance based on this analysis.
Further research would need to test whether the proposed link between management burden, daily restrictions and well-being explains the variability finding. Until then, the results add a short-term observational perspective on how glucose patterns relate to reported quality of life; they do not advise people to change glucose targets or diabetes treatment.
Key Questions
What did the diabetes study find?
In a 400-person analysis, more time in a 70–140 mg/dL glucose range and greater glucose variability on one day were each associated with better reported quality of life the next day.
Does the study say glucose swings are good for people with diabetes?
No. The study found an association and did not show that glucose swings improve health. The authors suggest that trying to prevent every fluctuation may sometimes add burden or restrictions, but that explanation has not been established as a cause.
How was quality of life measured?
Participants completed a daily assessment based on the WHO-5 questionnaire for 14 days. It asked about mood, calm, energy, feeling rested and interest in daily life.
Did time above or below the study’s glucose ranges relate to well-being?
The report says time above 180 mg/dL or below 70 mg/dL was not significantly associated with next-day quality of life. This does not mean those levels are safe or have no health effects.
When will the findings be presented?
The study is scheduled for presentation at the EASD Annual Meeting in Milan, Italy, from Sept. 28 to Oct. 2, 2026.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
